carbapenems has been researched along with Enteritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitoh, Y; Nishijima, E; Okata, Y; Tomioka, Y; Tsugawa, J | 1 |
| Buysschaert, I; Hermans, H; Rosseel, M; Spapen, J | 1 |
| Caballero, S; Carter, R; Ke, X; Kim, GJ; Leiner, IM; Ling, L; Manova, K; Miller, L; Pamer, EG; SuĊĦac, B | 1 |
3 other study(ies) available for carbapenems and Enteritis
| Article | Year |
|---|---|
Acute Onset Rectal Prolapse with a Pseudomembranous Covering.
Topics: Anti-Bacterial Agents; Carbapenems; Clostridioides difficile; Enteritis; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Rectal Prolapse | 2019 |
Campylobacter jejuni-related cardiomyopathy: Unknown entity or yet underreported?
Topics: Aminoglycosides; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Echocardiography; Enteritis; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Myocarditis | 2015 |
Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Drug Resistance, Bacterial; Enteritis; Enterococcus faecium; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Host-Pathogen Interactions; In Situ Hybridization, Fluorescence; Intestinal Mucosa; Klebsiella Infections; Klebsiella pneumoniae; Mice, Inbred C57BL; Microbial Interactions; Specific Pathogen-Free Organisms; Vancomycin-Resistant Enterococci | 2015 |